Buffett Just Bought Homebuilder: Berkshire Bets on Housing
Berkshire Hathaway agreed to acquire Taylor Morrison Home for roughly $8.5 billion, marking a major bet on the U.S. h...
Which Credit Card Is Good For Cash Back
Choosing the right credit card for cash back can boost your savings. Explore options that deliver the best return on your spending.
25,914 articlesSpaceX Successfully Completed IPO: 180-Day Investor Timeline
SpaceX has landed a historic IPO. This article lays out a 180-day plan for investors, with key dates, valuations, and...
Today’s Dividend Yield Least Isn’t the KPI Investors Need
As markets shift, today’s dividend yield least takes center stage in debates on income strategies. Growth and payout ...
Budget Airline Reinventing Itself Pulls Ahead in 2026
In 2026, the budget airline reinventing itself is pulling ahead as it monetizes upgrades and smarter distribution, wh...
Live: Will Oklo Smash Q1 Earnings Tonight, Market Reacts
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Eye-Watering SpaceX Spent Last Year Signals Big Bets Ahead
SpaceX reported a sharp rise in capital expenditures for 2025, with AI infrastructure leading the way. The eye-wateri...
Goldman Sachs Just Upgraded Tesla Deliveries: What It Means
A new forecast from Goldman Sachs signals stronger near-term Tesla deliveries. This article breaks down what the upgr...
What a $300,000 Portfolio Realistically Pays Each Month
As of July 8, 2026, investors are weighing how a $300,000 portfolio can yield steady monthly income. Three clear path...
Vistra’s 2026 Guidance Reinforces Its Growth Path Ahead
Vistra reports record 2025 EBITDA and unveils a 2026 target that points to sustained growth. The company cites long-t...
StubHub (Stub) 2026 Earnings: A Practical Investor Guide
Live events are back, but investors want proof StubHub can grow profits. This guide breaks down the stubhub (stub) 20...
Five Below (Five) 2026 Quarterly Insights: Q1 and Beyond
Five Below is navigating a evolving bargain-hunting landscape in 2026. This article breaks down a hypothetical Q1 202...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status